STOCKHOLDERS' EQUITY - Additional Information (Detail) (USD $)	1 Months Ended					3 Months Ended			1 Months Ended		12 Months Ended
	Sep. 09, 2011	Feb. 28, 2011	Jan. 01, 2006	Dec. 31, 2012	Mar. 31, 2012	Dec. 31, 2012 Additional Paid-In Capital [Member]	Dec. 31, 2012 Additional Paid-In Capital [Member] L.Y. Hong Kong Biotech Limited	Dec. 31, 2012 Retained Earnings [Member] L.Y. Hong Kong Biotech Limited	Sep. 09, 2011 Patent (U.S. No. 6,475,531 B1) L.Y. Hong Kong Biotech Limited	Feb. 28, 2011 Patent (U.S. No. 6,475,531 B1) L.Y. Hong Kong Biotech Limited	Sep. 30, 2012 Independent Directors	Mar. 31, 2012 Independent Directors
Class of Stock [Line Items]
Issuance of common shares to independent directors, value											$ 50	$ 22,222
Common stock shares issued to acquire patent		44,254,952								44,254,952
Consideration for patents acquired	2,765,992	32,748,665							2,765,992
Statutory reserve fund			10.00%
Maximum Statutory reserve fund to registered capital			50.00%
Statutory reserve				$ 956,633	$ 956,633
Cancellation of issued stock for return of patent (in shares)						0	32,704,410	32,748,664